Stockscreener 앱 받기
11.61
5.38%
-0.66
시간 외 거래:
12.75
1.14
+9.82%
전일 마감가:
$12.27
열려 있는:
$12.37
하루 거래량:
1.75M
Relative Volume:
2.75
시가총액:
$513.67M
수익:
$200.93M
순이익/손실:
$-18.91M
주가수익비율:
-26.27
EPS:
-0.4419
순현금흐름:
$-9.09M
1주 성능:
-13.03%
1개월 성능:
-9.58%
6개월 성능:
-36.28%
1년 성능:
-37.21%
1일 변동 폭
$11.48
$12.37
1주일 범위
$11.48
$13.67
52주 변동 폭
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
명칭
Si Bone Inc
전화
(408) 207-0700
주소
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
11.61 | 542.87M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-08 | 개시 | Citigroup | Buy |
| 2021-03-09 | 재확인 | Needham | Buy |
| 2020-12-16 | 재확인 | Needham | Buy |
| 2020-08-04 | 재확인 | Needham | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-05 | 재확인 | Needham | Buy |
| 2020-02-19 | 개시 | Needham | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | BofA/Merrill | Buy |
| 2018-11-12 | 개시 | Canaccord Genuity | Buy |
| 2018-11-12 | 개시 | JMP Securities | Mkt Outperform |
| 2018-11-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Si Bone Inc 주식(SIBN)의 최신 뉴스
SiBone Q1 Earnings Call Highlights - Yahoo Finance
SiBone Q1 2026 Earnings Call Transcript - MarketBeat
Is SI-BONE (SIBN) Still 45.2% Undervalued After Q1 2026 Beat? EP - GuruFocus
SIBN Reports Positive Outlook with Strong Gross Margin - GuruFocus
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
SIBN Reports Strong Q1 Performance with Revenue Growth - GuruFocus
SI-Bone (SIBN) Q1 2026 Earnings Transcript - The Globe and Mail
SI-BONE Q1 2026 slides: profitability surges, physician base expands - Investing.com
Earnings call transcript: Si-Bone Q1 2026 beats EPS forecast, stock rises - Investing.com
Si-Bone earnings beat by $0.09, revenue fell short of estimates - Investing.com Canada
SI-BONE Inc. (SIBN) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Si-Bone: Q1 Earnings Snapshot - marketscreener.com
[10-Q] SI-BONE, Inc. Quarterly Earnings Report - Stock Titan
SI-BONE Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SI-BONE (NASDAQ: SIBN) lifts 2026 outlook after double-digit Q1 growth - Stock Titan
BRIEF-SI-BONE Q1 Revenue USD 52.588 Million Vs. IBES Estimate USD 51.1 Million - TradingView
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance - marketscreener.com
Number of shareholders of SI-BONE, Inc. – SWB:2K3 - TradingView
How SI-BONE (SIBN) earnings track against industry trends | Q4 2025: Earnings Beat EstimatesEarnings Season - newser.com
First Light, Mathew Arens disclose 18% stake in SI-BONE (NASDAQ: SIBN) - Stock Titan
MSN Money - MSN
Earnings Preview: Si-Bone to Report Financial Results Post-market on May 11 - Moomoo
SI-BONE (SIBN) director Dunn sells small stake to cover RSU taxes - Stock Titan
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership - MSN
Price-Driven Insight from (SIBN) for Rule-Based Strategy - Stock Traders Daily
Hussman Strategic Advisors Inc. Purchases Shares of 84,000 SiBone $SIBN - MarketBeat
SiBone (NASDAQ:SIBN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026 - The Manila Times
SiBone (NASDAQ:SIBN) Short Interest Update - MarketBeat
Should I hold SI-BONE (SIBN) stock today | Q4 2025: EPS Exceeds ExpectationsWall Street Picks - Newser
SiBone (NASDAQ:SIBN) Hits New 52-Week LowTime to Sell? - MarketBeat
Needham maintains SI-BONE (SIBN) buy recommendation - MSN
Impax Asset Management Group plc Has $23.66 Million Stock Holdings in SiBone $SIBN - MarketBeat
BlackRock (SIBN) files Schedule 13G/A reporting 6.9% ownership of SI-BONE - Stock Titan
All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy - MSN
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - Moomoo
(SIBN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
SIBN (SI-BONE Inc.) Q4 2025 EPS far exceeds analyst estimates, shares gain roughly three percent today.Rating Upgrade - Xã Thanh Hà
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SI-BONE (NASDAQ: SIBN) sets 2026 virtual meeting, director and pay votes - Stock Titan
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026 - GlobeNewswire
Is SI-BONE (SIBN) stock worth trading today (Sideways) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
SiBone (NASDAQ:SIBN) Downgraded by Wall Street Zen to Hold - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) Q2 2025 Earnings Call Transcript - MSN
SiBone (NASDAQ:SIBN) Stock Price Down 4.8% on Analyst Downgrade - MarketBeat
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Truist Financial Lowers SiBone (NASDAQ:SIBN) Price Target to $20.00 - MarketBeat
Truist Cuts Price Target on SI-BONE to $20 From $24, Keeps Buy Rating - marketscreener.com
(SIBN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
SiBone (NASDAQ:SIBN) Shares Down 6.8%Here's Why - MarketBeat
SI-BONE’s Long-Term Vision Takes Hold: Record Revenue Growth, Positive Adjusted EBITDA, and Expanding Innovation and Distribution - Orthopedics This Week
Si Bone Inc (SIBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):